← Back to all trials
Not Yet Recruiting
NCT07733388
The Effectiveness Of Home-Based Circuit Training On Eye Pressure And Eye Nerve Structures In Patients With Glaucoma
Conditions: Glaucoma
Sex: All
Ages: 18 Years – 70 Years
Healthy volunteers: No
Phase: NA
Enrollment: 60
Sponsor: Universiti Sains Malaysia
Location: Universiti Sains Malaysia Kubang Kerian Kelantan
Summary
The goal of this randomised control trial is to learn about the effect of home based circuit training on patients with primary glaucoma.
The main questions to answer are:
1. Is there any difference of intraocular pressure (IOP) in patient with primary glaucoma after 6 weeks and 12 weeks who is performing home-based circuit training compared to patient not performing home-based circuit training?
2. Is there any difference of retina nerve fibre layer in patient with primary glaucoma after 6 weeks and 12 weeks who is performing home-based circuit training compared to patient not performing home-based circuit training?
3. Is there any difference of choroidal thickness layer in patient with primary glaucoma after 6 weeks and 12 weeks who is performing home-based circuit training compared to patient not performing home-based circuit training?
Researchers will compare patients with primary glaucoma who are performing home-based circuit training and not performing home-based circuit training to see if any affect to intraocular pressure, retina nerve fibre layer and choroidal thickness.
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 18 - 70 years old
* Known case of POAG, PACG, JOAG, NTG
* Phakic without visually significant cataract
* Pseudophakic for more than 3 months prior to recruitment
* Achieved target IOP
* Physically not performing routine exercises
Exclusion Criteria:
* Bilateral eye visual acuity of less than 6/60
* Bilateral eye visual field defect of less than 10 degrees from fixation
* Patient with media opacities that affect the reliability of OCT measurements such as cornea opacity, dense cataract with Lens opacification classification system (LOCS III) of more than grade 2, vitreous haemorrhage
* Patient who underwent intraocular surgery (other than uncomplicated cataract surgery), including anti-vascular endothelial growth factor injection within past 6 months
* Ocular disease such as cornea ulcer, uveitis, age-related macula degeneration
* Physical disabilities such as stroke, limbs amputation
* Uncontrolled systemic diseases eg diabetes, hypertension
* Morbid Obesity (BMI \> 40)
* Dementia or any psychiatric diseases
* Smoking
Source: ClinicalTrials.gov (NCT07733388). StuddyBuddy aggregates publicly available trial information.